Stock closed above its previous top, technical indicates stock will favor bulls as long as it holds above its previous top.
Stock was on news - Aurobindo Pharma stock gained 6.5% on USFDA nod to manufacture and market Sildenafil injection, use for treating pulmonary arterial hypertension in the american market, stock made a 52 weeks high in Indian share market, at NSE stock close around 1328. The company product is a genetic version of Pfizers Revatio injection.
No comments:
Post a Comment